These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35703495)

  • 1. Midodrine for Recurrent Vasovagal Syncope: A Systematic Review and Meta-analysis of Randomized Control Trials.
    Mhanna M; Beran A; Mhanna AS; Al-Abdouh A; Jabri A; Numan MJ; Alsaiqali M; Musallam R; Zerihun K; Mahmood A
    Am J Ther; 2024 Jan-Feb 01; 31(1):e87-e91. PubMed ID: 35703495
    [No Abstract]   [Full Text] [Related]  

  • 2. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Europace; 2022 Jul; 24(7):1171-1178. PubMed ID: 35025999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine treatment in children with recurrent vasovagal syncope.
    Bagrul D; Ece I; Yılmaz A; Atik F; Kavurt AV
    Cardiol Young; 2021 May; 31(5):817-821. PubMed ID: 33407967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midodrine for the treatment of vasovagal syncope (simple faint).
    Stewart JM
    J Pediatr; 2006 Dec; 149(6):740-2. PubMed ID: 17137884
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic approaches to therapy for vasovagal syncope.
    Calkins H
    Am J Cardiol; 1999 Oct; 84(8A):20Q-25Q. PubMed ID: 10568557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for the prevention of syncope trial IV: assessment of midodrine.
    Raj SR; Faris PD; McRae M; Sheldon RS
    Clin Auton Res; 2012 Dec; 22(6):275-80. PubMed ID: 22610268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic prevention of recurrent vasovagal syncope: A systematic review and network meta-analysis of randomized controlled trials.
    Behnoush AH; Yazdani K; Khalaji A; Tavolinejad H; Aminorroaya A; Jalali A; Tajdini M
    Heart Rhythm; 2023 Mar; 20(3):448-460. PubMed ID: 36509319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midodrine as a Treatment Option for Recurrent Vasovagal Syncope.
    Pearcy A; Rubideaux G; Garcha P; Meyer R
    Am Fam Physician; 2024 Jul; 110(1):74-75. PubMed ID: 39028785
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).
    Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W
    Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope.
    Samniah N; Sakaguchi S; Lurie KG; Iskos D; Benditt DG
    Am J Cardiol; 2001 Jul; 88(1):A7, 80-3. PubMed ID: 11423066
    [No Abstract]   [Full Text] [Related]  

  • 11. Midodrine for the Prevention of Vasovagal Syncope : A Randomized Clinical Trial.
    Sheldon R; Faris P; Tang A; Ayala-Paredes F; Guzman J; Marquez M; Morillo CA; Krahn AD; Kus T; Ritchie D; Safdar S; Maxey C; Raj SR;
    Ann Intern Med; 2021 Oct; 174(10):1349-1356. PubMed ID: 34339231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midodrine Is Worth a Trial in People With Frequent Episodes of Vasovagal Syncope.
    Shaughnessy AF
    Am Fam Physician; 2022 Apr; 105(4):Online. PubMed ID: 35426648
    [No Abstract]   [Full Text] [Related]  

  • 13. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
    Kaufmann H; Saadia D; Voustianiouk A
    Ann Neurol; 2002 Sep; 52(3):342-5. PubMed ID: 12205647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope].
    Liu XY; Wang C; Wu LJ; Hu CY; Lin P; Li MX; Cui XL; Xie ZW
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1951-4. PubMed ID: 19950567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient responding to combined therapy with pirmenol and midodrine for refractory neurally mediated syncope complicated by prostatic hypertrophy.
    Mizuguchi Y; Ishimoto T; Kageyama N; Oishi Y; Emi S; Nagase N; Oki T
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):405-8. PubMed ID: 15717144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine hydrochloride is safe and effective in older people with neurocardiogenic syncope.
    Paling D; Vilches-Moraga A; Akram Q; Atkinson O; Staniland JR; Paredes-Galán E
    J Am Geriatr Soc; 2010 Oct; 58(10):2026-7. PubMed ID: 20929474
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine.
    Amaki M; Kamide K; Takiuchi S; Niizuma S; Horio T; Kawano Y
    Int Heart J; 2007 Jan; 48(1):123-7. PubMed ID: 17379987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope.
    Qingyou Z; Junbao D; Chaoshu T
    J Pediatr; 2006 Dec; 149(6):777-80. PubMed ID: 17137891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data.
    Liao Y; Li X; Zhang Y; Chen S; Tang C; Du J
    Acta Paediatr; 2009 Jul; 98(7):1194-200. PubMed ID: 19397534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study.
    Perez-Lugones A; Schweikert R; Pavia S; Sra J; Akhtar M; Jaeger F; Tomassoni GF; Saliba W; Leonelli FM; Bash D; Beheiry S; Shewchik J; Tchou PJ; Natale A
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):935-8. PubMed ID: 11513446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.